Clinical Trial Update: Efficacy of Botulinum Toxin in Temporomandibular Disorders [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating botulinum toxin for temporomandibular joint disorders has completed testing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Temporomandibular Joint Disorder Bilateral

Drugs mentioned

• Botulinum toxin (botulinum toxin)

Snippet

Sponsor: University of Salamanca | Conditions: Temporomandibular Joint Disorder Bilateral | Phase 2, Phase 3 | Status: COMPLETED